Clinical Observation Of The In Advanced Non Small Cell Lung Cancer Of Phlegmy Wet Aggregates Type Lung

Objective:Through the observation of non small cell lung cancer patients in the treatment of advanced phlegm obstructing lung type, and to prove the therapeutic effect of Yu JinFang.Methods:From Collect 60 non small cell lung cancer patients coming to the Outpatient and hospitalized of Heilongjiang University of Chinese Medicine First Affiliated Hospital from June 2014 to December 2015, and divide them into two groups randomly, each group of 30 people. The diagnosis was confirmed by histological or cytological examination. At the end of the course, there were only 59 cases in the treatment group and 30 cases in the treatment group and 29 cases in the control group. Treatment group:Yu JinFang and Kanglaite Intravenous drip in the treatment, Yu JinFang even served, Kanglaite intravenous drip, continuous intravenous drip for 14 days,2 weeks of rest,28 day cycle; control group:Kanglaite intravenous drip, continuous intravenous drip for 14 days,2 weeks of rest,28 day cycle; treatment group and control group were continued for three cycles of chemotherapy. Observe and compare indexes of the two groups before and after treatment, such as the short-term efficacy, tumor markers CEA, ECOG, the change of TCM syndrome score.Results:1.the disease control rate of the treatment group was 86.67%, and the control group 65.52%.2.There were significant differences between the tumor markers CEA expression of the two groups before and after treatment (p<0.05); There were significant differences between the CEA expression of the two groups after treatment (p<0.05). It showed that the treatment group was better than the control group.3.The ECOG score of the two groups before and after treatment were significantly different(p<0.05) and the after treatment ECOG score of the two groups was significantly different (p<0.05), which showed that the treatment group was better than the control group.treatment ECOG of the two groups (p<0.05). It showed that the treatment group was better than the control group.4.There were significant differences between the TCM syndrome of the two groups before and after treatment of (p<0.05); There were significant differences between the afterConclusions:1.Yu Jin Fang effectively improved the disease control rate;2.Yu Jin Fang significantly depressed the level of tumor marks (CEA);3.Yu Jin Fang remarkable improved the physical condition due to reduce the score of ECOG4.Yu Jin Fang apparently improved the clinical symptoms by reducing the scores of TCM syndrome.